Pharmaceutical Industry Benefits from EAI
Specialized Services
EAI
offers specialized services to the
pharmaceutical industry, applying both to drug development and
to quality control of products. We meet the demands from our customers
regarding GMP compliance and strict confidentiality. EAI is experienced
in services with requirements for efficiency
and adherence to deadlines and standards. Our well-developed laboratory
infrastructure creates the conditions necessary for high productivity
and safety in delivery of highly accurate results.
![]()
Polysilicon testing may improve outputs
for solar and photovoltaic producers
EAI invites you to read our new white
paper on Polysilicon shortages and how Neutron
Activation Analysis (NAA) may help improve outputs by detecting
contaminants early – reducing wasted time and materials.
Concerns with global warming and fossil fuel depletion are driving
demand for alternative energy sources like photovoltaic fuel cells
and solar panels. Both industries rely heavily on silicon wafers
for production – and silicon purity is essential.
Test imports to reveal traces of heavy
metals
![]()
About Elemental Analysis, Inc.
Elemental Analysis, Inc. (EAI), a privately held company, is affiliated
with our sister company, Element Analysis Corp (EAC), which provided
industry with the first commercially dedicated
PIXE laboratory in the world. EAI recognized the need for
lower limits of detection and higher levels of accuracy –
without compromising customer service.
(Read More)


